Work on sensitive data without exposing clinical systems
Run research, test medical devices, and investigate threats in isolated environments, away from patient data and production systems.
- MRN 48213 · name
- DOB · address
- diagnosis · ssn
- subject 0481
- cohort · region
- diagnosis code
Meet the standards regulators and review boards expect
Standards & frameworks
- HIPAA
- FDA 21 CFR Part 11
- FDA cybersecurity guidance
- ISO 14971
Test the unknown without risking patients.
Healthcare and life sciences teams handle sensitive patient data and intellectual property under strict regulation, including HIPAA and FDA 21 CFR Part 11. Replica keeps that work off clinical systems entirely, meeting the standards regulators and review boards expect.
Testing a connected device or investigating ransomware on production infrastructure puts real patients and clinical operations at risk. With Replica, that same work runs in its own isolated environment, done in full, with an audit-ready record and nothing left behind.
What healthcare teams run on Replica
Five areas of sensitive work, each contained in its own isolated environment.
Secure research environments
Run R&D and clinical-trial work in isolation, protect datasets from exfiltration, and collaborate with CROs and academic partners, documented for review-board and regulatory compliance.
Cybersecurity operations
Investigate healthcare-specific ransomware and insider threats without exposing clinical systems, and rehearse incident response for clinical breaches.
Pharmaceutical intelligence
Research drug pipelines, trials, and patents anonymously, and evaluate M&A or licensing without revealing strategic intent.
Medical device security
Evaluate apps, APIs, and firmware without patient-data exposure, and validate against FDA cybersecurity guidance and ISO 14971.
Vendor and supply-chain validation
Test partners' ePHI handling and clinical integrations in isolation, with audit-ready documentation for vendor management.
- Environment createdsystem#a1f0
- Policy appliedsystem#b7c2
- Access grantedanalyst 04#4de9
- File savedanalyst 04#9a30
- Audit checkpointreviewer#f22c
Core capabilities
Secure research environments
Isolated spaces for R&D and clinical data, with no risk of leakage or IP theft.
Healthcare security operations
Threat hunting and incident response without exposing clinical systems or patient data.
Comprehensive audit
Verifiable records that support submissions, trial documentation, and inspections.
Global collaboration
Controlled access for distributed research teams and external partners.
Disposable environments
Spin up, run, and dispose with nothing left behind.
Ready in seconds
Stand up a compliant workspace without IT delays.
Questions about Replica for healthcare and life sciences
- Does Replica support HIPAA-regulated work?
- Replica keeps sensitive work, including ePHI, in isolated environments separated from clinical systems, and records every action for audit. Confirm your specific HIPAA and ePHI handling requirements with your compliance team before relying on the platform for regulated data.
- Can we test medical devices without touching patient data?
- Yes. Applications, APIs, and firmware run in isolated environments with no patient-data exposure, so teams can validate device security against FDA cybersecurity guidance and ISO 14971 away from clinical systems.
- Does Replica produce documentation for FDA and review boards?
- Replica maintains detailed, verifiable records of all activity that support submissions, clinical-trial documentation, and inspections. Confirm the specific evidentiary requirements for your submissions and review boards.
- Can external research partners collaborate securely?
- Yes. CROs, academic partners, and distributed teams share a governed environment with controlled access, so they collaborate without exposing datasets or methodologies. Every action is logged.